MusthInsider

Latest On Rhythm Pharmaceuticals, Inc (RYTM):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-08 15:06 EST	News	Rhythm Pharma wins Canadian nod for weight loss therapy	N/A
2023-05-03 02:24 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2023 Earnings Call Transcript	N/A
2023-05-03 02:24 EST	News	Rhythm Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation	N/A
2023-05-02 14:08 EST	News	Rhythm Pharmaceuticals reports misses Q1 top and bottom consensus; reaffirms FY23 outlook	N/A
2023-03-15 16:28 EST	News	Rhythm's Imcivree Warrants Caution Despite Clinical Progress	N/A
2023-03-11 04:02 EST	News	Rhythm Pharma has ~$3.4M in deposits with SVB Financial	N/A
2023-03-01 16:05 EST	News	Rhythm Pharmaceuticals beats Q4 top and bottom line estimates; initiates FY23 outlook	N/A
2023-03-01 16:05 EST	News	Rhythm Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation	N/A
2023-03-01 16:04 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2022 Earnings Call Transcript	N/A
2023-03-01 01:00 EST	News	Rhythm Pharmaceuticals Q4 2022 Earnings Preview	N/A
2023-02-27 19:24 EST	News	Rhythm Pharma acquires rare disease company Xinvento	N/A
2023-01-23 19:08 EST	News	Rhythm Pharma announces positive data from phase 3 trial of obesity treatment	N/A
2022-12-28 17:27 EST	News	Rhythm Pharma: An Incremental Approach Works Well For Setmelanotide	N/A
2022-12-09 06:42 EST	News	Rhythm Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation	N/A
2022-11-21 14:40 EST	News	Rhythm Pharma wins label expansion for obesity therapy in U.K.	N/A
2022-11-08 18:43 EST	News	Rhythm Pharmaceuticals GAAP EPS of -$0.79 beats by $0.22, revenue of $4.28M misses by $0.48M	N/A
2022-11-08 18:42 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2022 Earnings Call Transcript	N/A
2022-11-01 15:03 EST	News	Rhythm Pharma gains as FDA issues breakthrough status for weight loss agent	N/A
2022-10-10 16:52 EST	News	Rhythm Pharmaceuticals: Revisiting The Investment Thesis	N/A
2022-09-15 21:51 EST	News	Rhythm Pharmaceuticals stock slides on pricing stock offering at $26.00/share	N/A
2022-09-15 21:51 EST	News	Hot Stocks: FTCI and WYNN both gain, ADBE falls on acquisition news, RYTM drops more than 10%	N/A
2022-09-15 04:00 EST	News	Rhythm Pharmaceuticals announces $100M stock offering; shares fall 12% after hours	N/A
2022-09-07 06:53 EST	News	Rhythm Pharma's Imcivree drug gets expanded approval by European Commission for BBS	N/A
2022-08-09 07:36 EST	News	Rhythm Pharma adds 14% as Goldman upgrades on potential of wight loss agent	N/A
2022-08-02 20:37 EST	News	Rhythm Pharmaceuticals GAAP EPS of -$0.89 beats by $0.06, revenue of $2.31M misses by $0.26M	N/A
2022-08-02 20:37 EST	News	Rhythm Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation	N/A
2022-08-02 20:37 EST	News	Rhythm Pharma stock surges 21% on higher Q2 license revenue, genetic disorder drug Imcivree sales	N/A
2022-08-02 20:37 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-01 15:31 EST	News	Rhythm Pharmaceuticals Q2 2022 Earnings Preview	N/A
2022-08-01 15:31 EST	News	Rhythm Pharma: Rapidly Derisking Itself	N/A
2022-07-22 22:13 EST	News	Rhythm's obesity therapy Imcivree gets EMA panel nod for expanded use	N/A
2022-07-20 11:40 EST	News	Rhythm stock rises 20% as Imcivree gets early access nod in France for rare disorder	N/A
2022-07-18 17:53 EST	News	Rhythm Pharma gains as NICE recommends obesity drug	N/A
2022-07-13 20:47 EST	News	Rhythm Pharma extends gains to reach three-month high	N/A
2022-07-12 14:52 EST	News	Rhythm stock rises 9% as obesity therapy setmelanotide helps reduce BMI in mid-stage study	N/A
2022-06-23 01:33 EST	News	Rhythm Pharma launches Imcivree in Germany to treat obesity caused by deficiencies	N/A
2022-06-17 01:03 EST	News	FDA rejects Rhythm Pharma's application for its Imcivree medicine to treat Alström syndrome	N/A
2022-06-17 01:03 EST	News	Rhythm Pharma enters into financing agreement with Healthcare Royalty for up to $100M	N/A
2022-05-03 20:09 EST	News	Rhythm Pharmaceuticals GAAP EPS of -$1.05 misses by $0.04, revenue of $1.49M	N/A
2022-05-03 20:09 EST	News	Rhythm Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation	N/A
2022-05-03 20:09 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-03 01:57 EST	News	Rhythm Pharmaceuticals Q1 2022 Earnings Preview	N/A
2022-03-02 06:14 EST	News	Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q4 2021 Results - Earnings Call Transcript	N/A
2022-03-01 12:27 EST	News	Rhythm Pharmaceuticals GAAP EPS of -$0.85 beats by $0.06, revenue of $1.82M beats by $0.12M	N/A
2022-03-01 12:26 EST	News	Rhythm Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation	N/A
2022-02-28 18:15 EST	News	Rhythm Pharmaceuticals Q4 2021 Earnings Preview	N/A
2022-02-24 18:37 EST	News	Rhythm Pharma hit by delay in FDA review of label expansion for weight loss therapy	N/A
2022-02-18 01:06 EST	News	Rhythm Pharma gains after Ladenburg upgraded on potential of weight loss therapy	N/A
2022-01-15 20:08 EST	News	Rhythm Pharmaceuticals: PDUFA Ahead, But Commercialization Concerns Remain	N/A
2022-01-13 20:41 EST	News	Dosing underway in Rhythm Pharma's setmelanotide trial for rare genetic disease of obesity	N/A

About Rhythm Pharmaceuticals, Inc (RYTM):

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

See Advanced Chart

General

Name Rhythm Pharmaceuticals, Inc
Symbol RYTM
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 90
Fiscal Year EndDecember
IPO Date2017-10-05
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.rhythmtx.com

Valuation

Price/Book (Most Recent Quarter) 7.86

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$1.93
Next Year EPS Estimate -$2.44
Next Quarter EPS Estimate $0.90
Return on Assets -34%
Return on Equity -60%
Earnings Per Share -$3.34
Revenue Per Share $0
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 1.25 billion
EBITDA -120292000
PE Ratio -11.14
Analyst Target Price $46.25
Book Value Per Share $3.77

Share Statistics

Shares Outstanding 49.24 million
Shares Float 36.87 million
% Held by Insiders 347%
% Held by Institutions 91.48%
Shares Short 2.74 million
Shares Short Prior Month 2.94 million
Short Ratio 4.76
Short % of Float 7%
Short % of Shares Outstanding 5%

Technicals

Beta 1.53
52 Week High $43.26
52 Week Low $13.09
50 Day Moving Average 28.41
200 Day Moving Average 27.57

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Rhythm Pharmaceuticals, Inc (RYTM) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Rhythm Pharmaceuticals, Inc (RYTM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-01	$N/A	-$0.79	-$0.80	1.25%
2020-09-30	2020-11-02	$N/A	-$0.77	-$0.80	3.14%
2020-06-30	2020-08-03	$N/A	-$0.71	-$0.83	14.31%
2020-03-31	2020-05-04	$N/A	-$0.78	-$0.80	2.5%
2019-12-31	2020-03-02	$N/A	-$0.78	-$0.88	11.79%
2019-09-30	2019-11-01	$N/A	-$1.04	-$1.07	2.93%
2019-06-30	2019-07-29	$N/A	-$1.24	-$0.88	-41.6%
2019-03-31	2019-05-03	$N/A	-$0.84	-$0.76	-10.53%
2018-12-31	2019-03-08	$N/A	-$0.74	-$0.57	-28.92%
2018-09-30	2018-11-09	$N/A	-$0.52	-$0.46	-12.55%
2018-06-30	2018-08-08	$N/A	-$0.52	-$0.48	-8.33%
2018-03-31	2018-05-14	$N/A	-$0.60	-$0.45	-33.33%
2017-12-31	2018-03-12	$N/A	-$0.41	-$0.41	0%
2017-09-30	2017-11-14	$N/A	-$0.66	-$0.43	-53.49%

Rhythm Pharmaceuticals, Inc (RYTM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Rhythm Pharmaceuticals, Inc (RYTM) Chart:

Rhythm Pharmaceuticals, Inc (RYTM) News:

Below you will find a list of latest news for Rhythm Pharmaceuticals, Inc (RYTM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Rhythm Pharmaceuticals, Inc (RYTM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-06-20	35	0	CALL	0	0	276.06	TRUE	0	0
2025-06-20	40	0	CALL	0	0	233.23	TRUE	0	0
2025-06-20	45	0	CALL	0	0	187.9	TRUE	0	0
2025-06-20	50	12	CALL	0	1	137.9	TRUE	0	0
2025-06-20	55	0	CALL	0	1	92.95	TRUE	0	0
2025-06-20	60	5.35	CALL	2	31	45.07	TRUE	5.35	0
2025-06-20	65	2.65	CALL	37	662	39.64	TRUE	2.65	0
2025-06-20	70	0.83	CALL	26	911	40.4	FALSE	0.43	1.08
2025-06-20	75	0	CALL	0	978	70.49	FALSE	0	0
2025-06-20	80	0	CALL	0	2	88.51	FALSE	0	0
2025-06-20	85	0	CALL	0	0	104.57	FALSE	0	0
2025-06-20	90	0	CALL	0	0	119.56	FALSE	0	0
2025-06-20	35	0	PUT	0	0	205.33	FALSE	0	0
2025-06-20	40	0	PUT	0	0	188.56	FALSE	0	0
2025-06-20	45	0.34	PUT	0	2	152.87	FALSE	0	0
2025-06-20	50	0	PUT	0	0	120.18	FALSE	0	0
2025-06-20	55	0	PUT	0	200	86.35	FALSE	0	0
2025-06-20	60	1.1	PUT	0	121	62.1	FALSE	0	0
2025-06-20	65	2.7	PUT	3	1	54.78	FALSE	2.7	0
2025-06-20	70	0	PUT	0	0	47	TRUE	0	0
2025-06-20	75	0	PUT	0	0	53.88	TRUE	0	0
2025-06-20	80	0	PUT	0	0	53.49	TRUE	0	0
2025-06-20	85	0	PUT	0	0	66.36	TRUE	0	0
2025-06-20	90	0	PUT	0	0	78.11	TRUE	0	0
2025-07-18	25	0	CALL	0	1	236.68	TRUE	0	0
2025-07-18	30	0	CALL	0	0	203.64	TRUE	0	0
2025-07-18	35	0	CALL	0	0	175.36	TRUE	0	0
2025-07-18	40	0	CALL	0	0	140.92	TRUE	0	0
2025-07-18	45	0	CALL	0	0	48.74	TRUE	0	0
2025-07-18	50	0	CALL	0	15	58.14	TRUE	0	0
2025-07-18	55	0	CALL	0	1	55.41	TRUE	0	0
2025-07-18	60	6.7	CALL	0	40	56.38	TRUE	0	0
2025-07-18	65	5	CALL	2	791	49.08	TRUE	0.6	0.14
2025-07-18	70	2.67	CALL	6	197	46.14	FALSE	2.67	0
2025-07-18	75	0	CALL	0	5	49.66	FALSE	0	0
2025-07-18	80	0	CALL	0	1	57.83	FALSE	0	0
2025-07-18	85	0	CALL	0	6	66.82	FALSE	0	0
2025-07-18	90	0	CALL	0	17	75.34	FALSE	0	0
2025-07-18	95	0	CALL	0	7	83.37	FALSE	0	0
2025-07-18	25	0	PUT	0	0	132.71	FALSE	0	0
2025-07-18	30	0	PUT	0	14	169.34	FALSE	0	0
2025-07-18	35	0	PUT	0	39	141.03	FALSE	0	0
2025-07-18	40	0	PUT	0	4	82.46	FALSE	0	0
2025-07-18	45	0	PUT	0	150	95.82	FALSE	0	0
2025-07-18	50	0.65	PUT	0	1141	77.17	FALSE	0	0
2025-07-18	55	1.45	PUT	2	8	61.75	FALSE	-0.1	-0.06
2025-07-18	60	3.05	PUT	6	29	63.08	FALSE	3.05	0
2025-07-18	65	4.9	PUT	0	228	55.06	FALSE	0	0
2025-07-18	70	0	PUT	0	0	49.83	TRUE	0	0
2025-07-18	75	0	PUT	0	0	46.74	TRUE	0	0
2025-07-18	80	0	PUT	0	0	48.78	TRUE	0	0
2025-07-18	85	0	PUT	0	0	53.99	TRUE	0	0
2025-07-18	90	0	PUT	0	0	59.55	TRUE	0	0
2025-07-18	95	0	PUT	0	0	65.37	TRUE	0	0
2025-08-15	30	0	CALL	0	0	155.41	TRUE	0	0
2025-08-15	35	0	CALL	0	0	58.05	TRUE	0	0
2025-08-15	40	0	CALL	0	0	108.67	TRUE	0	0
2025-08-15	45	0	CALL	0	0	55.47	TRUE	0	0
2025-08-15	50	0	CALL	0	0	54.43	TRUE	0	0
2025-08-15	55	0	CALL	0	0	58.75	TRUE	0	0
2025-08-15	60	0	CALL	0	0	58.86	TRUE	0	0
2025-08-15	65	7.27	CALL	1	4	57.34	TRUE	7.27	0
2025-08-15	70	3.55	CALL	0	23	56.62	FALSE	0	0
2025-08-15	75	2	CALL	0	35	52.59	FALSE	0	0
2025-08-15	80	0	CALL	0	0	49.02	FALSE	0	0
2025-08-15	85	0	CALL	0	0	52.69	FALSE	0	0
2025-08-15	90	0	CALL	0	0	58	FALSE	0	0
2025-08-15	95	0	CALL	0	0	63.87	FALSE	0	0
2025-08-15	30	0	PUT	0	0	88.83	FALSE	0	0
2025-08-15	35	0	PUT	0	0	110.48	FALSE	0	0
2025-08-15	40	0.65	PUT	0	2	91.29	FALSE	0	0
2025-08-15	45	1.05	PUT	0	2	76.19	FALSE	0	0
2025-08-15	50	0	PUT	0	0	65.52	FALSE	0	0
2025-08-15	55	0	PUT	0	0	59.43	FALSE	0	0
2025-08-15	60	0	PUT	0	0	61.15	FALSE	0	0
2025-08-15	65	0	PUT	0	3	61.42	FALSE	0	0
2025-08-15	70	0	PUT	0	0	58.82	TRUE	0	0
2025-08-15	75	0	PUT	0	0	53.14	TRUE	0	0
2025-08-15	80	0	PUT	0	0	47.63	TRUE	0	0
2025-08-15	85	0	PUT	0	0	44.75	TRUE	0	0
2025-08-15	90	0	PUT	0	0	44.83	TRUE	0	0
2025-08-15	95	0	PUT	0	0	50.84	TRUE	0	0
2025-10-17	25	0	CALL	0	0	138.15	TRUE	0	0
2025-10-17	30	0	CALL	0	0	116.19	TRUE	0	0
2025-10-17	35	0	CALL	0	0	59.84	TRUE	0	0
2025-10-17	40	0	CALL	0	0	60.16	TRUE	0	0
2025-10-17	45	0	CALL	0	0	57.17	TRUE	0	0
2025-10-17	50	0	CALL	0	0	56.91	TRUE	0	0
2025-10-17	55	0	CALL	0	1	57.16	TRUE	0	0
2025-10-17	60	0	CALL	0	3	54.36	TRUE	0	0
2025-10-17	65	9	CALL	1	5	51.62	TRUE	9	0
2025-10-17	70	0	CALL	0	2	52.15	FALSE	0	0
2025-10-17	75	0	CALL	0	1	48.55	FALSE	0	0
2025-10-17	80	0	CALL	0	0	45.32	FALSE	0	0
2025-10-17	85	0	CALL	0	0	43.9	FALSE	0	0
2025-10-17	90	0	CALL	0	0	46.8	FALSE	0	0
2025-10-17	95	0	CALL	0	0	48.37	FALSE	0	0
2025-10-17	25	0	PUT	0	3	117.19	FALSE	0	0
2025-10-17	30	0	PUT	0	3	97.88	FALSE	0	0
2025-10-17	35	0	PUT	0	3	83.19	FALSE	0	0
2025-10-17	40	0	PUT	0	1	71.85	FALSE	0	0
2025-10-17	45	0	PUT	0	1	63.77	FALSE	0	0
2025-10-17	50	0	PUT	0	0	59.76	FALSE	0	0
2025-10-17	55	0	PUT	0	36	58.14	FALSE	0	0
2025-10-17	60	0	PUT	0	2	56.33	FALSE	0	0
2025-10-17	65	0	PUT	0	0	54.07	FALSE	0	0
2025-10-17	70	0	PUT	0	0	52.58	TRUE	0	0
2025-10-17	75	0	PUT	0	0	48.93	TRUE	0	0
2025-10-17	80	0	PUT	0	0	46.9	TRUE	0	0
2025-10-17	85	0	PUT	0	0	44.67	TRUE	0	0
2025-10-17	90	0	PUT	0	0	44.27	TRUE	0	0
2025-10-17	95	0	PUT	0	0	43.94	TRUE	0	0
2025-12-19	20	0	CALL	0	0	138.97	TRUE	0	0
2025-12-19	22.5	0	CALL	0	0	125.35	TRUE	0	0
2025-12-19	25	0	CALL	0	0	117.08	TRUE	0	0
2025-12-19	30	0	CALL	0	1	58.59	TRUE	0	0
2025-12-19	35	0	CALL	0	0	62.43	TRUE	0	0
2025-12-19	40	0	CALL	0	2	61.09	TRUE	0	0
2025-12-19	45	0	CALL	0	1	58	TRUE	0	0
2025-12-19	50	0	CALL	0	59	57.13	TRUE	0	0
2025-12-19	55	0	CALL	0	1	55.21	TRUE	0	0
2025-12-19	60	12.1	CALL	0	17	53.12	TRUE	0	0
2025-12-19	65	0	CALL	0	7	52.72	TRUE	0	0
2025-12-19	70	7.45	CALL	0	2	50.37	FALSE	0	0
2025-12-19	75	0	CALL	0	2	48.32	FALSE	0	0
2025-12-19	80	0	CALL	0	2	46.45	FALSE	0	0
2025-12-19	85	0	CALL	0	0	44.86	FALSE	0	0
2025-12-19	90	0	CALL	0	0	42.3	FALSE	0	0
2025-12-19	95	0	CALL	0	0	43.58	FALSE	0	0
2025-12-19	20	0	PUT	0	9	79.86	FALSE	0	0
2025-12-19	22.5	0	PUT	0	4	77.39	FALSE	0	0
2025-12-19	25	0	PUT	0	2	98.06	FALSE	0	0
2025-12-19	30	0	PUT	0	3	68.12	FALSE	0	0
2025-12-19	35	0	PUT	0	0	74.11	FALSE	0	0
2025-12-19	40	0	PUT	0	1	65.47	FALSE	0	0
2025-12-19	45	0	PUT	0	0	61.67	FALSE	0	0
2025-12-19	50	0	PUT	0	3	58.72	FALSE	0	0
2025-12-19	55	0	PUT	0	0	56.52	FALSE	0	0
2025-12-19	60	0	PUT	0	1	54.78	FALSE	0	0
2025-12-19	65	0	PUT	0	1	52.77	FALSE	0	0
2025-12-19	70	0	PUT	0	0	50.73	TRUE	0	0
2025-12-19	75	0	PUT	0	0	49.4	TRUE	0	0
2025-12-19	80	0	PUT	0	0	47.48	TRUE	0	0
2025-12-19	85	0	PUT	0	0	45.8	TRUE	0	0
2025-12-19	90	0	PUT	0	0	44.23	TRUE	0	0
2025-12-19	95	0	PUT	0	0	41.2	TRUE	0	0
2026-01-16	30	0	CALL	0	0	58.93	TRUE	0	0
2026-01-16	35	0	CALL	0	0	57.48	TRUE	0	0
2026-01-16	40	0	CALL	0	0	57.73	TRUE	0	0
2026-01-16	45	0	CALL	0	0	54.66	TRUE	0	0
2026-01-16	50	0	CALL	0	0	53.03	TRUE	0	0
2026-01-16	55	0	CALL	0	0	52.25	TRUE	0	0
2026-01-16	60	0	CALL	0	0	51.08	TRUE	0	0
2026-01-16	65	0	CALL	0	0	49.88	TRUE	0	0
2026-01-16	70	0	CALL	0	0	48.44	FALSE	0	0
2026-01-16	75	0	CALL	0	0	47.06	FALSE	0	0
2026-01-16	80	0	CALL	0	0	45.82	FALSE	0	0
2026-01-16	85	0	CALL	0	0	44.73	FALSE	0	0
2026-01-16	30	0	PUT	0	0	66.57	FALSE	0	0
2026-01-16	35	0	PUT	0	0	67.85	FALSE	0	0
2026-01-16	40	0	PUT	0	0	60.42	FALSE	0	0
2026-01-16	45	0	PUT	0	0	55.09	FALSE	0	0
2026-01-16	50	0	PUT	0	0	54.58	FALSE	0	0
2026-01-16	55	0	PUT	0	0	53.29	FALSE	0	0
2026-01-16	60	0	PUT	0	0	51.44	FALSE	0	0
2026-01-16	65	0	PUT	0	0	50.88	FALSE	0	0
2026-01-16	70	0	PUT	0	0	49.97	TRUE	0	0
2026-01-16	75	0	PUT	0	0	47.83	TRUE	0	0
2026-01-16	80	0	PUT	0	0	46.96	TRUE	0	0
2026-01-16	85	0	PUT	0	0	46.28	TRUE	0	0

Latest RYTM Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	70	$3.16
Jun 13, 2022 7:59 PM EST	200	$3.165
Jun 13, 2022 7:59 PM EST	12	$3.17
Jun 13, 2022 7:59 PM EST	400	$3.165
Jun 13, 2022 7:59 PM EST	100	$3.165

Rhythm Pharmaceuticals, Inc (RYTM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080639/0001104659-20-080639-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000007800319000011/0000078003-19-000011-index.htm
2020-02-07	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000083423720008171/0000834237-20-008171-index.htm
2018-09-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000089924318023708/0000899243-18-023708-index.htm
2020-01-28	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000090221920000225/0000902219-20-000225-index.htm
2018-06-27	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1649904/000094787118000531/0000947871-18-000531-index.htm
2018-08-10	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1649904/000094787118000633/0000947871-18-000633-index.htm
2018-06-21	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1649904/000104746918004669/0001047469-18-004669-index.htm
2018-11-09	S-3ASR	Automatic shelf registration statement of securities of well-known seasoned issuers	https://www.sec.gov/Archives/edgar/data/1649904/000104746918007171/0001047469-18-007171-index.htm
2019-04-30	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1649904/000104746919002750/0001047469-19-002750-index.htm
2019-10-15	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1649904/000104746919005747/0001047469-19-005747-index.htm
2019-10-16	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1649904/000104746919005768/0001047469-19-005768-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1649904/000104746920002717/0001047469-20-002717-index.htm
2018-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465918050938/0001104659-18-050938-index.htm
2018-08-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918051945/0001104659-18-051945-index.htm
2018-09-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918055584/0001104659-18-055584-index.htm
2018-09-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2018-10-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918062552/0001104659-18-062552-index.htm
2018-10-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918062553/0001104659-18-062553-index.htm
2018-11-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066381/0001104659-18-066381-index.htm
2018-11-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066382/0001104659-18-066382-index.htm
2018-11-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465918067286/0001104659-18-067286-index.htm
2018-11-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465918067400/0001104659-18-067400-index.htm
2018-12-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465918071680/0001104659-18-071680-index.htm
2019-01-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919001165/0001104659-19-001165-index.htm
2019-01-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002328/0001104659-19-002328-index.htm
2019-01-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002494/0001104659-19-002494-index.htm
2019-01-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002735/0001104659-19-002735-index.htm
2019-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919003144/0001104659-19-003144-index.htm
2019-02-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919005511/0001104659-19-005511-index.htm
2019-02-13	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1649904/000110465919007907/0001104659-19-007907-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009039/0001104659-19-009039-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009040/0001104659-19-009040-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009041/0001104659-19-009041-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009042/0001104659-19-009042-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009043/0001104659-19-009043-index.htm
2019-02-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009044/0001104659-19-009044-index.htm
2019-02-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009555/0001104659-19-009555-index.htm
2019-02-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919011530/0001104659-19-011530-index.htm
2019-03-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919013632/0001104659-19-013632-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015281/0001104659-19-015281-index.htm
2019-03-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015985/0001104659-19-015985-index.htm
2019-03-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919018231/0001104659-19-018231-index.htm
2019-05-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919026866/0001104659-19-026866-index.htm
2019-05-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919031448/0001104659-19-031448-index.htm
2019-05-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2019-06-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919033437/0001104659-19-033437-index.htm
2019-06-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037012/0001104659-19-037012-index.htm
2019-06-21	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037014/0001104659-19-037014-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037016/0001104659-19-037016-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037017/0001104659-19-037017-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037018/0001104659-19-037018-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037019/0001104659-19-037019-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919037021/0001104659-19-037021-index.htm
2019-07-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919040345/0001104659-19-040345-index.htm
2019-07-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919040756/0001104659-19-040756-index.htm
2019-07-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919041836/0001104659-19-041836-index.htm
2019-07-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919042308/0001104659-19-042308-index.htm
2019-07-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919042309/0001104659-19-042309-index.htm
2019-07-29	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919042312/0001104659-19-042312-index.htm
2019-08-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919043324/0001104659-19-043324-index.htm
2019-08-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919044424/0001104659-19-044424-index.htm
2019-08-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919045574/0001104659-19-045574-index.htm
2019-09-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919051296/0001104659-19-051296-index.htm
2019-10-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919054191/0001104659-19-054191-index.htm
2019-10-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919054422/0001104659-19-054422-index.htm
2019-10-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919054991/0001104659-19-054991-index.htm
2019-10-18	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000110465919055004/0001104659-19-055004-index.htm
2019-11-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919058997/0001104659-19-058997-index.htm
2019-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465919060306/0001104659-19-060306-index.htm
2019-12-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/0001104659-19-077301-index.htm
2020-01-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920002248/0001104659-20-002248-index.htm
2020-01-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920002850/0001104659-20-002850-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920003024/0001104659-20-003024-index.htm
2020-01-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920008015/0001104659-20-008015-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920019193/0001104659-20-019193-index.htm
2020-02-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920022826/0001104659-20-022826-index.htm
2020-02-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920022827/0001104659-20-022827-index.htm
2020-02-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920022828/0001104659-20-022828-index.htm
2020-02-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920022830/0001104659-20-022830-index.htm
2020-02-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920025380/0001104659-20-025380-index.htm
2020-03-02	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1649904/000110465920027924/0001104659-20-027924-index.htm
2020-03-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920027934/0001104659-20-027934-index.htm
2020-03-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920031918/0001104659-20-031918-index.htm
2020-03-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920034073/0001104659-20-034073-index.htm
2020-03-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920040577/0001104659-20-040577-index.htm
2020-03-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920041297/0001104659-20-041297-index.htm
2020-04-24	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000110465920050946/0001104659-20-050946-index.htm
2020-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1649904/000110465920053582/0001104659-20-053582-index.htm
2020-06-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074642/0001104659-20-074642-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074729/0001104659-20-074729-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074730/0001104659-20-074730-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074731/0001104659-20-074731-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074732/0001104659-20-074732-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074733/0001104659-20-074733-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920074734/0001104659-20-074734-index.htm
2020-06-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920078081/0001104659-20-078081-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080534/0001104659-20-080534-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080535/0001104659-20-080535-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080536/0001104659-20-080536-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080538/0001104659-20-080538-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080639/0001104659-20-080639-index.htm
2020-07-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920085303/0001104659-20-085303-index.htm
2020-07-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920085305/0001104659-20-085305-index.htm
2020-07-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920085306/0001104659-20-085306-index.htm
2020-08-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920089387/0001104659-20-089387-index.htm
2020-08-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920094656/0001104659-20-094656-index.htm
2020-09-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/0001104659-20-101370-index.htm
2020-09-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920105657/0001104659-20-105657-index.htm
2020-10-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920112635/0001104659-20-112635-index.htm
2020-10-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000110465920112638/0001104659-20-112638-index.htm
2020-11-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1649904/000110465920120294/0001104659-20-120294-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000114420419007229/0001144204-19-007229-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000114420419008305/0001144204-19-008305-index.htm
2019-02-12	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1649904/000119312519034375/0001193125-19-034375-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000119312519037940/0001193125-19-037940-index.htm
2020-02-05	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1649904/000119312520025330/0001193125-20-025330-index.htm
2020-02-05	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000119312520025430/0001193125-20-025430-index.htm
2020-06-26	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1649904/000119312520180810/0001193125-20-180810-index.htm
2019-08-19	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000119380519000752/0001193805-19-000752-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000119380520000188/0001193805-20-000188-index.htm
2019-02-11	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119008847/0001209191-19-008847-index.htm
2019-06-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119038465/0001209191-19-038465-index.htm
2019-11-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119057850/0001209191-19-057850-index.htm
2019-11-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058110/0001209191-19-058110-index.htm
2019-11-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058413/0001209191-19-058413-index.htm
2019-12-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058905/0001209191-19-058905-index.htm
2019-12-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060024/0001209191-19-060024-index.htm
2019-12-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060391/0001209191-19-060391-index.htm
2020-03-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020304/0001209191-20-020304-index.htm
2020-03-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020959/0001209191-20-020959-index.htm
2020-03-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120021729/0001209191-20-021729-index.htm
2020-04-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120022104/0001209191-20-022104-index.htm
2020-04-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120026323/0001209191-20-026323-index.htm
2020-05-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120027738/0001209191-20-027738-index.htm
2020-05-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120028594/0001209191-20-028594-index.htm
2020-05-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120029837/0001209191-20-029837-index.htm
2020-05-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120030985/0001209191-20-030985-index.htm
2020-05-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032086/0001209191-20-032086-index.htm
2020-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032719/0001209191-20-032719-index.htm
2020-06-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034119/0001209191-20-034119-index.htm
2020-06-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034680/0001209191-20-034680-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120037709/0001209191-20-037709-index.htm
2020-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120038956/0001209191-20-038956-index.htm
2020-06-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1649904/000120919120039471/0001209191-20-039471-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000127417319000105/0001274173-19-000105-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000127417320000047/0001274173-20-000047-index.htm
2020-05-11	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1649904/000127417320000106/0001274173-20-000106-index.htm
2018-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837018006765/0001558370-18-006765-index.htm
2018-11-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837018009110/0001558370-18-009110-index.htm
2019-03-08	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1649904/000155837019001698/0001558370-19-001698-index.htm
2019-05-03	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837019003924/0001558370-19-003924-index.htm
2019-07-29	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837019006464/0001558370-19-006464-index.htm
2019-11-01	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837019009647/0001558370-19-009647-index.htm
2020-03-02	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1649904/000155837020001896/0001558370-20-001896-index.htm
2020-05-04	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837020004983/0001558370-20-004983-index.htm
2020-08-03	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837020008958/0001558370-20-008958-index.htm
2020-11-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1649904/000155837020012208/0001558370-20-012208-index.htm
2020-08-17	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1649904/999999999720004400/9999999997-20-004400-index.htm

Rhythm Pharmaceuticals, Inc (RYTM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rhythm Pharmaceuticals, Inc (RYTM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 347%
Institutional Ownership: 9148%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2018-08-10	Nithya Desikan	Chief Commercial Officer	Buy	14,534.00	6.88	99,993.92	14,534.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918051945/0001104659-18-051945-index.htm
2019-07-11	Hunter C Smith	Chief Financial Officer	Buy	10,000.00	6.88	68,800.00	16,000.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919040345/0001104659-19-040345-index.htm
2020-06-26	Todd Foley	Director	Sell	300.00	25.04	7,512.00	1,909,258.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120039471/0001209191-20-039471-index.htm
2020-06-25	Todd Foley	Director	Sell	17,947.00	25.41	456,033.27	1,909,558.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120038956/0001209191-20-038956-index.htm
2020-06-24	Todd Foley	Director	Sell	97,388.00	25.34	2,467,811.92	1,927,505.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120038956/0001209191-20-038956-index.htm
2020-06-05	Todd Foley	Director	Sell	1,896.00	20.00	37,920.00	2,024,893.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034680/0001209191-20-034680-index.htm
2020-06-03	Todd Foley	Director	Sell	18,245.00	20.27	369,826.15	2,026,789.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034119/0001209191-20-034119-index.htm
2020-06-02	Todd Foley	Director	Sell	15,578.00	20.23	315,142.94	2,045,034.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034119/0001209191-20-034119-index.htm
2020-06-01	Todd Foley	Director	Sell	10,535.00	20.08	211,542.80	2,060,612.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120034119/0001209191-20-034119-index.htm
2020-05-28	Todd Foley	Director	Sell	19,152.00	20.19	386,678.88	2,071,147.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032719/0001209191-20-032719-index.htm
2020-05-27	Todd Foley	Director	Sell	10,148.00	20.13	204,279.24	2,090,299.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032719/0001209191-20-032719-index.htm
2020-05-26	Todd Foley	Director	Sell	44,421.00	20.47	909,297.87	2,100,447.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032086/0001209191-20-032086-index.htm
2020-05-22	Todd Foley	Director	Sell	26,906.00	20.13	541,617.78	2,144,868.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032086/0001209191-20-032086-index.htm
2020-05-21	Todd Foley	Director	Sell	25,594.00	20.25	518,278.50	2,171,774.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120032086/0001209191-20-032086-index.htm
2020-05-20	Todd Foley	Director	Sell	10,527.00	20.01	210,645.27	2,197,368.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120030985/0001209191-20-030985-index.htm
2020-05-19	Todd Foley	Director	Sell	2,633.00	20.00	52,660.00	2,207,895.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120030985/0001209191-20-030985-index.htm
2020-05-18	Todd Foley	Director	Sell	21,349.00	20.00	426,980.00	2,210,528.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120030985/0001209191-20-030985-index.htm
2020-01-28	Hunter C Smith	Chief Financial Officer	Buy	6,250.00	6.88	43,000.00	22,250.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920008015/0001104659-20-008015-index.htm
2020-05-13	Todd Foley	Director	Sell	1,837.00	20.04	36,813.48	2,231,877.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120029837/0001209191-20-029837-index.htm
2020-05-12	Todd Foley	Director	Sell	24,342.00	20.23	492,438.66	2,233,714.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120028594/0001209191-20-028594-index.htm
2020-05-11	Todd Foley	Director	Sell	22,155.00	20.34	450,632.70	2,258,056.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120028594/0001209191-20-028594-index.htm
2020-05-08	Todd Foley	Director	Sell	6,633.00	20.05	132,991.65	2,280,211.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120028594/0001209191-20-028594-index.htm
2020-05-07	Todd Foley	Director	Sell	200.00	20.01	4,002.00	2,286,844.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120027738/0001209191-20-027738-index.htm
2020-05-06	Todd Foley	Director	Sell	1,626.00	20.00	32,520.00	2,287,044.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120027738/0001209191-20-027738-index.htm
2020-04-29	Todd Foley	Director	Sell	20,397.00	20.12	410,387.64	2,288,670.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120026323/0001209191-20-026323-index.htm
2020-04-28	Todd Foley	Director	Sell	15,826.00	20.07	317,627.82	2,309,067.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120026323/0001209191-20-026323-index.htm
2020-04-01	Todd Foley	Director	Sell	15,462.00	15.10	233,476.20	2,324,893.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120022104/0001209191-20-022104-index.htm
2020-03-31	Todd Foley	Director	Sell	19,108.00	15.16	289,677.28	2,340,355.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120022104/0001209191-20-022104-index.htm
2020-03-26	Todd Foley	Director	Sell	2,300.00	15.04	34,592.00	2,359,463.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120021729/0001209191-20-021729-index.htm
2020-03-20	Todd Foley	Director	Sell	1,100.00	15.00	16,500.00	2,361,763.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020959/0001209191-20-020959-index.htm
2020-03-19	Todd Foley	Director	Sell	8,200.00	15.07	123,574.00	2,362,863.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020304/0001209191-20-020304-index.htm
2020-03-18	Todd Foley	Director	Sell	12,781.00	15.14	193,504.34	2,371,063.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020304/0001209191-20-020304-index.htm
2020-03-17	Todd Foley	Director	Sell	9,653.00	15.12	145,953.36	2,383,844.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919120020304/0001209191-20-020304-index.htm
2019-12-12	Todd Foley	Director	Sell	3,762.00	25.01	94,087.62	2,393,497.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060391/0001209191-19-060391-index.htm
2019-12-11	Todd Foley	Director	Sell	13,600.00	25.14	341,904.00	2,397,259.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060391/0001209191-19-060391-index.htm
2019-12-10	Todd Foley	Director	Sell	41,839.00	25.36	1,061,037.04	2,410,859.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060024/0001209191-19-060024-index.htm
2019-12-09	Todd Foley	Director	Sell	22,195.00	25.04	555,762.80	2,452,698.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119060024/0001209191-19-060024-index.htm
2019-12-03	Todd Foley	Director	Sell	16,777.00	22.33	374,630.41	2,474,893.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058905/0001209191-19-058905-index.htm
2019-12-02	Todd Foley	Director	Sell	25,366.00	22.03	558,812.98	2,491,670.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058905/0001209191-19-058905-index.htm
2019-11-29	Todd Foley	Director	Sell	18,359.00	22.67	416,198.53	2,517,036.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058413/0001209191-19-058413-index.htm
2019-11-27	Todd Foley	Director	Sell	34,960.00	22.91	800,933.60	2,535,395.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058413/0001209191-19-058413-index.htm
2019-11-26	Todd Foley	Director	Sell	74,225.00	23.31	1,730,184.75	2,570,355.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058413/0001209191-19-058413-index.htm
2020-03-13	Hunter C Smith	Chief Financial Officer	Buy	3,500.00	6.88	24,080.00	25,750.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920034073/0001104659-20-034073-index.htm
2019-11-25	Todd Foley	Director	Sell	50,320.00	23.34	1,174,468.80	2,644,580.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058110/0001209191-19-058110-index.htm
2019-11-25	Todd Foley	Director	Sell	71,023.00	23.04	1,636,369.92	2,694,900.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058110/0001209191-19-058110-index.htm
2019-11-22	Todd Foley	Director	Sell	1,171.00	22.04	25,808.84	2,765,923.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058110/0001209191-19-058110-index.htm
2019-11-22	Todd Foley	Director	Sell	101,511.00	21.78	2,210,909.58	2,767,094.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119058110/0001209191-19-058110-index.htm
2019-11-21	Todd Foley	Director	Sell	5,457.00	21.09	115,088.13	2,868,605.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119057850/0001209191-19-057850-index.htm
2019-11-21	Todd Foley	Director	Sell	59,466.00	20.50	1,219,053.00	2,874,062.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119057850/0001209191-19-057850-index.htm
2019-08-12	Nithya Desikan	Chief Commercial Officer	Buy	14,534.00	6.88	99,993.92	29,068.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919045574/0001104659-19-045574-index.htm
2019-12-27	Nithya Desikan	Chief Commercial Officer	Sell	35,181.00	22.79	801,771.47	29,068.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/0001104659-19-077301-index.htm
2019-11-20	Todd Foley	Director	Sell	141,365.00	22.02	3,112,857.30	2,933,528.00	https://www.sec.gov/Archives/edgar/data/1649904/000120919119057850/0001209191-19-057850-index.htm
2020-03-30	Hunter C Smith	CFO and Interim CEO	Buy	3,900.00	6.88	26,832.00	29,650.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920041297/0001104659-20-041297-index.htm
2018-09-05	Hunter C Smith	Chief Financial Officer	Buy	3,000.00	6.88	20,640.00	3,000.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918055584/0001104659-18-055584-index.htm
2019-01-16	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	200.00	30.00	6,000.00	42,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002494/0001104659-19-002494-index.htm
2019-05-28	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	10,000.00	25.38	253,800.00	42,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2019-05-29	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	5,000.00	25.51	127,550.00	42,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2019-05-30	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	5,000.00	25.31	126,550.00	42,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919033437/0001104659-19-033437-index.htm
2019-05-31	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	5,000.00	25.10	125,500.00	42,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919033437/0001104659-19-033437-index.htm
2018-11-02	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	38,000.00	30.09	1,143,420.00	42,539.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066381/0001104659-18-066381-index.htm
2020-08-11	Nithya Desikan	Chief Commercial Officer	Buy	14,534.00	6.88	99,993.92	43,602.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920094656/0001104659-20-094656-index.htm
2020-08-31	Nithya Desikan	Chief Commercial Officer	Sell	25,000.00	30.00	750,000.00	43,602.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/0001104659-20-101370-index.htm
2019-05-29	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	5,000.00	4.59	22,950.00	47,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2019-05-30	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	5,000.00	4.59	22,950.00	47,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919033437/0001104659-19-033437-index.htm
2019-05-31	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	5,000.00	4.59	22,950.00	47,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919033437/0001104659-19-033437-index.htm
2019-03-18	Keith Michael Gottesdiener	CEO & President	Sell	2,329.00	30.27	70,498.83	506,342.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015985/0001104659-19-015985-index.htm
2019-03-15	Keith Michael Gottesdiener	CEO & President	Sell	7,961.00	30.04	239,148.44	508,671.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015985/0001104659-19-015985-index.htm
2019-07-16	Keith Michael Gottesdiener	CEO and President	Buy	7,500.00	4.59	34,425.00	513,842.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919040756/0001104659-19-040756-index.htm
2020-07-02	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	44,153.00	22.04	972,968.75	5,140,408.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080639/0001104659-20-080639-index.htm
2019-03-14	Keith Michael Gottesdiener	CEO & President	Sell	1,506.00	30.05	45,255.30	516,632.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015281/0001104659-19-015281-index.htm
2019-03-13	Keith Michael Gottesdiener	CEO & President	Sell	7,782.00	30.06	233,926.92	518,138.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919015281/0001104659-19-015281-index.htm
2020-07-01	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	25,527.00	21.87	558,311.23	5,184,561.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080639/0001104659-20-080639-index.htm
2020-06-30	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	61,901.00	22.15	1,371,237.14	5,210,088.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920080639/0001104659-20-080639-index.htm
2019-05-28	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	9,860.00	4.59	45,257.40	52,199.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2019-05-28	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	140.00	6.14	859.60	52,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919032725/0001104659-19-032725-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	6,102.00	31.86	194,409.72	52,339.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2019-02-27	Keith Michael Gottesdiener	CEO and President	Sell	1,814.00	30.01	54,438.14	525,617.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919011530/0001104659-19-011530-index.htm
2020-06-29	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	52,049.00	22.19	1,154,998.54	5,271,989.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920078081/0001104659-20-078081-index.htm
2019-02-26	Keith Michael Gottesdiener	CEO and President	Sell	635.00	30.13	19,132.55	527,431.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919011530/0001104659-19-011530-index.htm
2019-02-19	Keith Michael Gottesdiener	CEO and President	Sell	918.00	30.05	27,585.90	528,066.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009555/0001104659-19-009555-index.htm
2019-02-15	Keith Michael Gottesdiener	CEO and President	Sell	12,002.00	30.02	360,300.04	528,984.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009555/0001104659-19-009555-index.htm
2020-06-26	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	86,706.00	23.31	2,020,848.07	5,324,038.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920078081/0001104659-20-078081-index.htm
2019-02-13	Keith Michael Gottesdiener	CEO and President	Sell	3,934.00	30.00	118,020.00	540,986.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919009043/0001104659-19-009043-index.htm
2020-06-25	RA CAPITAL MANAGEMENT, L.P.	10% Share Holder	Sell	11,568.00	25.05	289,767.99	5,410,744.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920078081/0001104659-20-078081-index.htm
2019-01-23	Keith Michael Gottesdiener	CEO and President	Sell	105.00	30.21	3,172.05	544,920.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919003144/0001104659-19-003144-index.htm
2019-01-22	Keith Michael Gottesdiener	CEO and President	Sell	15,674.00	30.05	471,003.70	545,025.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919003144/0001104659-19-003144-index.htm
2020-01-08	Keith Michael Gottesdiener	CEO & President	Buy	33,072.00	4.59	151,800.48	546,914.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920003024/0001104659-20-003024-index.htm
2020-02-10	Keith Michael Gottesdiener	CEO & President	Buy	6,816.00	6.14	41,850.24	554,283.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920019193/0001104659-20-019193-index.htm
2020-03-09	Keith Michael Gottesdiener	CEO & President	Buy	3,408.00	6.14	20,925.12	558,250.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920031918/0001104659-20-031918-index.htm
2019-01-18	Keith Michael Gottesdiener	CEO & President	Sell	10,115.00	30.01	303,551.15	560,699.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002735/0001104659-19-002735-index.htm
2019-01-16	Keith Michael Gottesdiener	CEO & President	Sell	662.00	30.00	19,860.00	570,814.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919002328/0001104659-19-002328-index.htm
2018-12-03	Keith Michael Gottesdiener	CEO and President	Sell	563.00	30.00	16,890.00	571,476.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918071680/0001104659-18-071680-index.htm
2018-11-02	Keith Michael Gottesdiener	CEO and President	Sell	16,500.00	30.08	496,320.00	572,039.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066382/0001104659-18-066382-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	5,304.00	30.60	162,302.40	58,441.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2019-01-31	Hunter C Smith	Chief Financial Officer	Buy	3,000.00	6.88	20,640.00	6,000.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919005511/0001104659-19-005511-index.htm
2018-11-02	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	8,200.00	4.59	37,638.00	60,539.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066381/0001104659-18-066381-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	7,656.00	29.81	228,225.36	63,745.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2019-12-27	Nithya Desikan	Chief Commercial Officer	Buy	35,181.00	6.88	242,045.28	64,249.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/0001104659-19-077301-index.htm
2020-08-31	Nithya Desikan	Chief Commercial Officer	Buy	25,000.00	6.88	172,000.00	68,602.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/0001104659-20-101370-index.htm
2018-11-02	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	10,000.00	6.14	61,400.00	70,539.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066381/0001104659-18-066381-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	9,052.00	28.88	261,421.76	71,401.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Sell	3,686.00	27.45	101,180.70	80,453.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm
2018-11-02	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	10,000.00	7.52	75,200.00	80,539.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918066381/0001104659-18-066381-index.htm
2018-09-25	der Ploeg Leonardus H.T. Van	Chief Scientific Officer	Buy	21,800.00	4.59	100,062.00	84,139.00	https://www.sec.gov/Archives/edgar/data/1649904/000110465918059105/0001104659-18-059105-index.htm

Rhythm Pharmaceuticals, Inc

(NASDAQ:RYTM)